ANFF-NSW facilitated chip encapsulation, identifying a bioresin compatible with the Nanoscribe 3D-printing system and advising on bio-glass fabrication. Validated prototypes demonstrate the promise of this monitoring device to improve health outcomes for support animals.

Following successful prototype development, ANFF-C funding will support iQ Sense to advance its technology by developing, testing, and validating production-ready prototypes for commercial deployment.

Designed to bridge the gap between technical achievement and commercial opportunity, Gate 2 funding enables ANFF-supported ventures to access the specialist services needed for their next stage of growth. Support of up to $135,000 can be directed towards activities that strengthen commercial readiness and help companies tackle the challenges that often emerge between prototype development and market adoption. ANFF-C Director John Morrison works with recipients to identify the support activities most relevant to their technology and business objectives.

By supporting companies at critical points in their development, ANFF-C helps ensure promising Australian innovations continue their path towards real-world impact. ANFF looks forward to following iQ Sense as it progresses towards delivering new tools for animal health monitoring and care.

For more information about iQ Sense, visit https://www.iqsense.tech

To learn more about ANFF-C and ANFF’s support for commercialisation, visit http://anff.org.au/commercialisation/